|
Video: What is a Stock Split?
|
|
Athenex is a biopharmaceutical company focused on the discovery, development and commercialization of products for the treatment of cancer. Co. manages its operations in two reportable segments: Oncology Innovation Platform, which is focused on the research and development of its proprietary drugs and; Commercial Platform, which focused on the sales and marketing of drugs and the market development of its proprietary drugs. Co. is also continuing certain studies of oral paclitaxel and encequidar, the active product candidate using its Orascovery technology, based on a P-glycoprotein pump inhibitor. According to our ATNX split history records, ATNX has had 1 split. | |
|
ATNX (ATNX) has 1 split in our ATNX split history database. The split for ATNX took place on February 15, 2023. This was a 1 for 20 reverse split, meaning for each 20 shares of ATNX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as ATNX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ATNX split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ATNX shares, starting with a $10,000 purchase of ATNX, presented on a split-history-adjusted basis factoring in the complete ATNX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/15/2017 |
|
End date: |
05/24/2023 |
|
Start price/share: |
$273.60 |
|
End price/share: |
$0.20 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.93% |
|
Average Annual Total Return: |
-70.26% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7.42 |
|
Years: |
5.94 |
|
|
|
Date |
Ratio |
02/15/2023 | 1 for 20 |
|
|